Arcutis Biotherapeutics to Participate in Major Healthcare Conference
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a biopharmaceutical company in the commercial stage that specializes in innovative solutions for immuno-dermatology, is set to take part in an important healthcare conference. This event offers Arcutis a platform to showcase its advancements in dermatology while engaging with key stakeholders in the industry.
About Arcutis Biotherapeutics
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is dedicated to meeting the unmet needs of individuals suffering from immune-mediated dermatological conditions. As a commercial-stage entity, Arcutis is focused on delivering significant innovations in medical dermatology, particularly for conditions that present ongoing challenges for patients.
Innovative Product Portfolio
Arcutis boasts a diverse product portfolio that features three FDA-approved therapies, all developed using the company’s proprietary dermatology platform. This platform combines years of specialized knowledge to create treatments that target validated biological pathways, with the ultimate goal of enhancing the quality of life for patients dealing with dermatological diseases.
Pipeline and Future Developments
The company’s extensive pipeline is continually growing, with clinical programs aimed at a wide range of inflammatory dermatological conditions. These initiatives encompass treatments for scalp and body psoriasis, atopic dermatitis, and alopecia areata—conditions that greatly affect patients’ quality of life. Arcutis is at the forefront of dermatological innovation, working diligently to provide solutions that address critical patient needs.
Event Participation Details
During the conference, Arcutis will participate in a fireside chat. Here are the details:
- Fireside Chat Date: Thursday, September 5
- Fireside Chat Time: 1:50 PM ET
Those interested can tune in to the live webcast of the discussion through the Events section of the company’s website. For anyone unable to attend, a recorded replay will be available for 180 days after the event, ensuring continued access to the valuable insights shared during the presentation.
Company Commitment
Arcutis is firmly committed to advancing dermatological care through its innovative products and research initiatives. The company is focused on overcoming persistent challenges in dermatology, establishing Arcutis as a leader within the biopharmaceutical sector.
Contact Information
For further inquiries, please reach out to:
Media Inquiries:
Amanda Sheldon, Head of Corporate Communications
Email: media@arcutis.com
Investor Relations:
Latha Vairavan, Vice President, Finance and Investor Relations
Email: ir@arcutis.com
Frequently Asked Questions
What is Arcutis Biotherapeutics known for?
Arcutis Biotherapeutics is known for its commitment to innovation in immuno-dermatology and the development of therapies for immune-mediated dermatological diseases.
When will Arcutis hold its fireside chat?
The fireside chat is scheduled for Thursday, September 5 at 1:50 PM ET.
How can stakeholders access the conference?
Stakeholders can access the conference webcast through the Events section on Arcutis's official website.
What types of diseases does Arcutis focus on?
Arcutis focuses on treating a variety of inflammatory dermatological conditions, including psoriasis, atopic dermatitis, and alopecia areata.
Who can I contact for media inquiries?
For media inquiries, you can reach out to Amanda Sheldon at media@arcutis.com.